Experience

Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $650 million aggregate principal amount of 3.100% senior notes due 2026, fully and unconditionally guaranteed by…

Davis Polk advised The Metropolis of Tokyo in connection with its $1 billion Rule 144A/Regulation S offering of 2.000% bonds due 2021. The offering was the Metropolis’s first-ever U.S…

Davis Polk advised the joint book-running managers in connection with a $41.4 million SEC-registered common stock offering of 1,926,250 shares of common stock of Loxo Oncology, Inc…

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Davis Polk is advising Morgan Stanley as financial adviser to Memorial Resource Development Corp. on its $4.4 billion acquisition by Range Resources Corporation in an all-stock transaction…

Davis Polk advised the joint book-running managers on an SEC-registered offering of $400 million aggregate principal amount of 3.75% senior notes due 2046. Headquartered in Lake…

Davis Polk advised Noble Americas Corp., Noble Petro Inc., and Noble Americas Gas & Power Corp. in connection with their $2 billion asset-based revolving credit facility. Loans and…

On May 11, 2016, the U.S. Bankruptcy Court for the District of Delaware granted with prejudice a motion to dismiss brought by a group of senior secured lenders to RadioShack (the “ABL…

Davis Polk is advising Petrobras in connection with their sale of an indirect 67.19% stake in Petrobras Argentina to Pampa Energía for $892 million. Petrobras operates as an integrated…

Davis Polk advised the representatives of the underwriters, in connection with an SEC-registered offering by AbbVie Inc. (“AbbVie”) of $7.8 billion aggregate principal amount of senior…